Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBV.
Davis C. et al, (2024), Vaccines, 12
HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV.
Cargill T. et al, (2023), JHEP reports : innovation in hepatology, 5
NK cells limit therapeutic vaccine-induced CD8+T cell immunity in a PD-L1-dependent manner.
Diniz MO. et al, (2022), Science translational medicine, 14
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study.
Marjot T. et al, (2021), Journal of hepatology, 74, 567 - 577
The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases.
Cargill T. and Culver EL., (2021), Frontiers in immunology, 12
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study
Webb GJ. et al, (2020), The Lancet Gastroenterology & Hepatology, 5, 1008 - 1016
High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry.
Moon AM. et al, (2020), Journal of hepatology, 73, 705 - 708
Experience from the first UK inter-regional specialist multidisciplinary meeting in the diagnosis and management of IgG4-related disease.
Goodchild G. et al, (2020), Clinical medicine (London, England), 20, e32 - e39
The Design and Development of a Multi-HBV Antigen Encoded in Chimpanzee Adenoviral and Modified Vaccinia Ankara Viral Vectors; A Novel Therapeutic Vaccine Strategy against HBV
Chinnakannan SK. et al, (2020), Vaccines, 8, 184 - 184
Unique patterns of glycosylation in immunoglobulin subclass G4-related disease and primary sclerosing cholangitis
Culver EL. et al, (2019), Journal of Gastroenterology and Hepatology, 34, 1878 - 1886
A systematic review of comorbidities and outcomes of adult patients with pleural infection.
Cargill TN. et al, (2019), The European respiratory journal, 54
Correction: Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and Pancreatitis.
Cargill T. et al, (2019), Clinical and translational gastroenterology, 10
Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults.
Green CA. et al, (2019), The Journal of infection, 78, 382 - 392
Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and Pancreatitis
Cargill T. et al, (2019), Clinical and Translational Gastroenterology, 10, e00020 - e00020
PYY plays a key role in the resolution of diabetes following bariatric surgery in humans
Guida C. et al, (2019), EBioMedicine, 40, 67 - 76
Clinical Manifestations and Long-term Outcomes of IgG4-Related Kidney and Retroperitoneal Involvement in a United Kingdom IgG4-Related Disease Cohort
Evans RDR. et al, (2019), Kidney International Reports, 4, 48 - 58
A novel chimpanzee adenoviral vectored HBV vaccine, encoding multiple HBV antigens with a shark invariant chain adjuvant, for use in HBV immunotherapy
Chinnakannan SK. et al, (2018), JOURNAL OF HEPATOLOGY, 68, S789 - S790
Thoracic involvement in IgG4-related disease in a UK-based patient cohort
Corcoran JP. et al, (2017), Respiratory Medicine, 132, 117 - 121